Organization
Rebiotix
2 clinical trials
Clinical trial
A Phase 3 Open-Label Clinical Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (Microbiota Suspension) in Subjects With Recurrent Clostridium Difficile InfectionStatus: Completed, Estimated PCD: 2023-07-21
Clinical trial
A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of RBX2660 (Microbiota Suspension) for the Prevention of Clostridium Difficile InfectionStatus: Completed, Estimated PCD: 2020-04-02